An Adaptable High-Throughput Technology Enabling the Identification of Specific Transcription Modulators

Area of Science:

• Mitochondrial biology
• Molecular genetics
• Drug discovery

Background:

• Mitochondria generate cellular energy (ATP) via oxidative phosphorylation (OXPHOS).
• Mitochondrial DNA encodes essential OXPHOS components, transcribed by mitochondrial RNA polymerase (POLRMT).
• Mitochondrial transcription levels correlate with cellular respiratory activity, suggesting therapeutic targets.

Purpose of the Study:

• To establish a high-throughput assay for screening compounds affecting mitochondrial transcription.
• To identify novel compounds that modulate mitochondrial gene expression.
• To explore potential therapeutic applications for metabolic diseases and cancer.

Main Methods:

• Developed a novel high-throughput assay for in vitro screening of mitochondrial transcription.
• Screened a library of 430,000 diverse compounds.
• Conducted secondary screens to validate and confirm compound activity.

Main Results:

• Identified 55 compounds that efficiently and selectively inhibit mitochondrial transcription.
• Confirmed that identified compounds are active in cell culture.
• The assay technology is adaptable to other polymerases and detection methods.

Conclusions:

• Novel high-throughput assay enables efficient screening of mitochondrial transcription modulators.
• Identified compounds offer potential for fine-tuning cellular metabolism.
• These findings may lead to new treatments for metabolic disorders and certain cancers.